Product Name: Retatrutide

Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, supplied as a sterile injectable solution

Each package contains a total of 40 mg, divided into 4 individual doses of 10 mg, designed for subcutaneous administration only.

Product Details

• Active compound: Retatrutide

• Total strength: 40 mg

• Dosage format: 4 × 10 mg doses

• Route of administration: Subcutaneous injection only

• Form: Injectable solution

Storage Instructions

• Store refrigerated at 2°C to 8°C

• Do not freeze

• Keep out of direct light

Important Information

• Read the package leaflet carefully before use

• For professional or prescribed use only

• Not intended for oral or intravenous administration